indie Semiconductor Q2 Revenue Beats Guidance, Loss Narrows; Wuxi Divestiture Still Pending
INDI sits 74% above its 52-week low of $2.32.
Summary
indie Semiconductor's Q2 revenue of $64M beat guidance and grew 24% YoY, while the net loss narrowed. The pending Wuxi divestiture and continued insider selling remain key investor concerns.
Key Events · Earnings and Guidance · INDI
-
Q2 Revenue Beats Guidance
Revenue of $64.0 million grew 24% year-over-year and exceeded the company's own guidance, driven by higher product volumes.
-
Net Loss Narrows
Net loss attributable to indie was $37.1 million ($0.17/share), improving from $39.0 million ($0.20/share) in Q2 2025, helped by lower restructuring costs.
-
Cash Burn Continues
Operating activities used $51.0 million in H1 2026; cash and equivalents fell to $149.0 million from $155.7 million at year-end 2025.
-
Wuxi Divestiture Still Pending
The sale of the Wuxi subsidiary, which accounted for 44% of Q2 revenue, remains subject to Chinese regulatory approvals with no closing date set.
Analysis · INDI · Manufacturing
indie Semiconductor posted Q2 revenue of $64 million, up 24% year-over-year and above its own guidance, while the net loss narrowed to $37.1 million from $39.0 million a year ago. The company continues to burn cash — operating activities used $51 million in the first half — but ended the quarter with $149 million in cash and equivalents. The pending sale of its Wuxi subsidiary, which still generates over 40% of revenue, remains a major overhang; closing is subject to Chinese regulatory approvals with no firm timeline. A director also adopted a 10b5-1 trading plan for up to 59,932 shares, adding to a pattern of insider selling over the past quarter.
At the time of this filing, INDI was trading at $4.04 on NASDAQ in the Manufacturing sector, with a market capitalization of approximately $916.7M. The 52-week trading range was $2.32 to $6.05. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.